Philip A. Sharp, Director at BIOGEN IDEC INC. (BIIB), sold 15,650 shares at $64.65 ($1.0M) on 2008-04-08, disclosed to the SEC on 2008-04-10.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.45 | 1,450 | $93K | 9.2% |
| 2 | $64.46 | 1,103 | $71K | 7.0% |
| 3 | $64.47 | 97 | $6K | 0.6% |
| 4 | $64.49 | 400 | $26K | 2.6% |
| 5 | $64.50 | 800 | $52K | 5.1% |
| 6 | $64.51 | 200 |
| $13K |
| 1.3% |
| 7 | $64.52 | 900 | $58K | 5.7% |
| 8 | $64.53 | 700 | $45K | 4.5% |
| 9 | $64.54 | 400 | $26K | 2.6% |
| 10 | $64.55 | 800 | $52K | 5.1% |
| 11 | $64.56 | 200 | $13K | 1.3% |
| 12 | $64.58 | 400 | $26K | 2.6% |
| 13 | $64.61 | 300 | $19K | 1.9% |
| 14 | $64.63 | 500 | $32K | 3.2% |
| 15 | $64.64 | 700 | $45K | 4.5% |
| 16 | $64.65 | 30 | $2K | 0.2% |
| 17 | $64.66 | 100 | $6K | 0.6% |
| 18 | $64.67 | 300 | $19K | 1.9% |
| 19 | $64.68 | 200 | $13K | 1.3% |
| 20 | $64.69 | 223 | $14K | 1.4% |
| 21 | $64.70 | 2,000 | $129K | 12.8% |
| 22 | $64.71 | 270 | $17K | 1.7% |
| 23 | $64.72 | 600 | $39K | 3.8% |
| 24 | $64.73 | 100 | $6K | 0.6% |
| 25 | $64.74 | 700 | $45K | 4.5% |
| 26 | $64.75 | 200 | $13K | 1.3% |
| 27 | $64.76 | 100 | $6K | 0.6% |
| 28 | $64.78 | 100 | $6K | 0.6% |
| 29 | $64.79 | 700 | $45K | 4.5% |
| 30 | $64.80 | 1,077 | $70K | 6.9% |
| Total | $64.61 avg | 15,650 | $1.0M | 100% |
| Filing → |
| ALNY | SELL | 2018-03-13 | $1.9M | — | Filing → |
| ALNY | SELL | 2017-02-03 | $2.0M | — | Filing → |
| ALNY | SELL | 2017-01-27 | $569K | — | Filing → |